Cover Image

Blood Safety and Availability : Managing Supply to Meet a Growing Demand.

Provides background information on Federal oversight and regulation of blood bank industry, which collects blood from voluntary donors for transfusions. Discusses several issues regarding new data on blood supply and demand and recent FDA actions to address blood safety and availability.

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2000.
Series:	U.S. Congressional Research.
Subjects:	Blood. Medical laws and legislation. Product safety. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Blood and blood products : safety and risk /
Published: (1996)

Blood safety and availability : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives ; One Hundred Sixth Congress, first session ; September 23, October 6, and October 19, 1999.
Published: (1999)

Blood safety and availability : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, first session, September 23, October 6, and October 19, 1999.
Published: (1999)

FDA regulation of blood safety : notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997.
Published: (1998)

Blood : Collection, Testing, and Processing.
Published: (1987)

Protecting the Nation's Blood Supply from Infectious Agents : The Need for New Standards To Meet New Threats.
Published: (1996)

Blood safety, minimizing plasma product risks : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, September 9, 1998.
Published: (1999)

Biotechnology of blood /
Published: (1991)

Blood, blood products, and AIDS /
Published: (1987)

Meeting the challenges of blood safety in the 21st century : pathogen inactivations /
Published: (2004)

The safety of the blood supply /
by: Redhead, C. Stephen
Published: (1992)

Safety of the Blood Supply.
Published: (1992)

Blood supply safety : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, July 28, 1993.
Published: (1993)

Blood supply safety : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, April 18 and May 15, 1991.
Published: (1991)

FDA regulation of blood safety : notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997.
Published: (1998)

Keeping blood transfusions safe : FDA's multi-layered protections for donated blood.
Published: (2002)

Blood supply safety : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, July 19, 1990.
Published: (1990)

Biotechnology of blood /
Published: (1991)

Drug Safety and Effectiveness : Issues and Action Options After FDA Approval.
Published: (2005)

Blood safety, minimizing plasma product risks : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, September 9, 1998.
Published: (1999)

Drug Safety : A Side-by-Side Comparison of Bills in the 110th Congress.
Published: (2007)

Drug Safety and Effectiveness : Issues and Action Options After FDA Approval.
Published: (2007)

The market for human blood /
by: Hough, Douglas E.
Published: (1978)

Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood /
Published: (2021)

Blood substitutes /
Published: (2006)

Blood transfusion /
by: Keynes, Geoffrey, 1887-1982, et al.
Published: (1949)

Blood and Blood Products : Federal Regulation and Tort Liability.
Published: (1996)

Blood and blood products : federal regulation and tort liability /
by: Duffy, Diane T.
Published: (1996)

Blood grouping in relation to clinical and legal medicine /
by: Snyder, Laurence Hasbrouck, 1901-
Published: (1929)

Blood safety : enhancing safeguards would strengthen the nation's blood supply : statement of Bernice Steinhardt, Director, Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources, Committee on Government Reform and Oversight, House of Representatives /
by: Steinhardt, Bernice
Published: (1997)

Human blood for transfusion.
Published: (1926)

Biotechnology in blood transfusion : proceedings of the Twelfth Annual Symposium on Blood Transfusion, Groningen, 1987 /
Published: (1988)

Making safe blood available in Africa : hearing and briefing before the Subcommittee on Africa, Global Human Rights, and International Operations of the Committee on International Relations, House of Representatives, One Hundred Ninth Congress, second session, June 27, 2006.
Published: (2006)

Making safe blood available in Africa : hearing and briefing before the Subcommittee on Africa, Global Human Rights, and International Operations of the Committee on International Relations, House of Representatives, One Hundred Ninth Congress, second session, June 27, 2006.
Published: (2006)

Court Decisions Involving the Right To Refuse Blood Transfusions.
Published: (1967)

FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.
Published: (1998)

FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.
Published: (1998)

Consumer product safety issues /
Published: (2009)

European regulation of consumer product safety /
by: Hodges, Christopher J. S.
Published: (2005)

Modern blood banking and transfusion practices /
Published: (2005)